FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Sandoz Cefazolin Recall

Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use v…

Sandoz Incorporated · Broomfield, CO

Risk level
Class II
Reported by FDA
Jun 19, 2013
Recall ID
D-597-2013
Check your lot numberHow we source this data

Summary

Sandoz recalled Cefazolin starting May 30, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-597-2013 on Jun 19, 2013. Reason: Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples.

Product description

Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use vial, Manufactured in Austria by Sandoz GmbH for Sandoz, Inc. Princeton, NJ 08540, NDC 00781-3451-70 (vial), NDC 00781-3451-96 (box)

Lot numbers, UPCs & expiration codes

Lot #: DB2208, Exp 01/16

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-597-2013
Classification
Class II
Status
Terminated
Recall initiated
May 30, 2013
FDA report date
Jun 19, 2013
Quantity
297,200 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Sandoz Incorporated

Original FDA data

Every field from FDA enforcement report D-597-2013, exactly as published.

Show all FDA fields
City
Broomfield
State
CO
Status
Terminated
Country
United States
Event ID
65318
Address
2555 W Midway Blvd
Code information
Lot #: DB2208, Exp 01/16
Postal code
80020-1632
Report date
Jun 19, 2013
Product type
Drugs
Recall number
D-597-2013
Classification
Class II
Recalling firm
Sandoz Incorporated
Product quantity
297,200 vials
Termination date
Jul 7, 2014
Reason for recall
Lack of Assurance of Sterility: Sandoz Inc is recalling Cefazolin for Injection, USP 1 gm vials, lot DB2208, due to a customer complaint for broken/cracked vials which was confirmed through review of retained samples.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use vial, Manufactured in Austria by Sandoz GmbH for Sandoz, Inc. Princeton, NJ 08540, NDC 00781-3451-70 (vial), NDC 00781-3451-96 (box)
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
May 30, 2013
Initial firm notification
Letter
Center classification date
Jun 11, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-597-2013, published Jun 19, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls